{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:16:44Z","timestamp":1778570204439,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017291","name":"Zhongshan Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017291","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014945","name":"Guangzhou University of Chinese Medicine Science and Technology Innovation Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Protein Expression and Purification"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.pep.2026.106916","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T07:08:59Z","timestamp":1773126539000},"page":"106916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Construction of a novel B7H3 VHH-Fc antibody with potent antitumor activity and NK\/T cell activation"],"prefix":"10.1016","volume":"241","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0428-8679","authenticated-orcid":false,"given":"Ailing","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caiyi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengcheng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guojian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanhuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pep.2026.106916_bib1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.pep.2026.106916_bib2","first-page":"77","article-title":"Innate and adaptive immune cells in tumor microenvironment, the gulf","volume":"1","author":"Shrihari","year":"2021","journal-title":"J. Oncol."},{"key":"10.1016\/j.pep.2026.106916_bib3","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.4049\/jimmunol.172.4.2352","article-title":"Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-Like domains","volume":"172","author":"Steinberger","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.pep.2026.106916_bib4","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/cr.2017.90","article-title":"Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function","volume":"27","author":"Lee","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.pep.2026.106916_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1152\/ajplung.00132.2003","article-title":"Expression of genes for B7-H3 and other T cell ligands by nasal epithelial cells during differentiation and activation","volume":"287","author":"Saatian","year":"2004","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.pep.2026.106916_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41423-019-0305-2","article-title":"Tumor-expressed B7-H3 mediates the inhibition of antitumor T-cell functions in ovarian cancer insensitive to PD-1 blockade therapy","volume":"17","author":"Cai","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.pep.2026.106916_bib7","doi-asserted-by":"crossref","first-page":"12640","DOI":"10.1073\/pnas.0405025101","article-title":"Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis","volume":"101","author":"Castriconi","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pep.2026.106916_bib8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0888-7543(03)00126-5","article-title":"Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss","volume":"82","author":"Ling","year":"2003","journal-title":"Genomics"},{"key":"10.1016\/j.pep.2026.106916_bib9","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1038\/sj.bjc.6605375","article-title":"Clinical importance of B7-H3 expression in human pancreatic cancer","volume":"101","author":"Yamato","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.pep.2026.106916_bib10","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1748991","article-title":"B7-H3 inhibits the IFN-\u03b3-dependent cytotoxicity of V\u03b39V\u03b42 T cells against colon cancer cells","volume":"9","author":"Lu","year":"2020","journal-title":"OncoImmunology"},{"key":"10.1016\/j.pep.2026.106916_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.28936","article-title":"The novel non\u2010immunological role and underlying mechanisms of B7\u2010H3 in tumorigenesis","volume":"234","author":"Zhou","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"12","key":"10.1016\/j.pep.2026.106916_bib12","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1002\/ijc.28474","article-title":"B7-H3-mediated tumor immunology, Friend or foe?","volume":"134","author":"Wang","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"14","key":"10.1016\/j.pep.2026.106916_bib13","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1158\/1078-0432.CCR-12-0715","article-title":"Development of an Fc-Enhanced Anti-B7-H3 monoclonal antibody with potent antitumor activity","volume":"18","author":"Loo","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.pep.2026.106916_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.nucmedbio.2017.01.003","article-title":"B7-H3-targeted 212Pb radioimmunotherapy of ovarian cancer in preclinical models","volume":"47","author":"Kasten","year":"2017","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.pep.2026.106916_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/S0959-8049(20)31102-3","article-title":"DS-7300a, a novel B7-H3-targeting antibody-drug conjugate with a novel DNA topoisomerase I inhibitor DXd, exhibits potent anti-tumor effects in nonclinical models - ScienceDirect","volume":"138","author":"Yamato","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.pep.2026.106916_bib16","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/08830185.2022.2102619","article-title":"B7-H3-targeted CAR-T cell therapy for solid tumors","volume":"41","author":"Li","year":"2022","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.pep.2026.106916_bib17","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.15_suppl.TPS5099","article-title":"Phase II neoadjuvant and immunologic study of B7-H3 targeting with enoblituzumab in localized intermediate- and high-risk prostate cancer","volume":"36","author":"Shenderov","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.pep.2026.106916_bib18","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1158\/2767-9764.CRC-25-0293","article-title":"A phase I, open-label, dose escalation study of enoblituzumab in children and young adults with B7-H3-Expressing relapsed or refractory solid tumors","volume":"5","author":"DeSantes","year":"2025","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.pep.2026.106916_bib19","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.4049\/jimmunol.181.6.4062","article-title":"B7-H3 contributes to the development of pathogenic Th2 cells in a murine model of asthma","volume":"181","author":"Nagashima","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.pep.2026.106916_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3069","article-title":"Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fc\u03b3 receptor binding properties","volume":"13","author":"Nordstrom","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.pep.2026.106916_bib21","unstructured":"C. Wang, Y.-L. Chen, X. Liu, W. Luo, G. Liu, H. Li, Y. Lin, B7-H3 NANOBODY AND PREPARATION METHOD THEREFOR AND USE THEREOF."},{"key":"10.1016\/j.pep.2026.106916_bib22","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/348552a0","article-title":"Phage antibodies: filamentous phage displaying antibody variable domains","volume":"348","author":"Mccafferty","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.pep.2026.106916_bib23","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1074\/jbc.M806889200","article-title":"General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold","volume":"284","author":"Vincke","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pep.2026.106916_bib24","doi-asserted-by":"crossref","first-page":"37128","DOI":"10.18632\/oncotarget.16201","article-title":"Gene-modified NK-92MI cells expressing a chimeric CD16-BB-\u03b6 or CD64-BB-\u03b6 receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.pep.2026.106916_bib25","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","article-title":"Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells","volume":"174","author":"Shultz","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.pep.2026.106916_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101420","article-title":"A bispecific antibody targeting HER2 and PD-L1 inhibits tumor growth with superior efficacy","author":"Chen","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pep.2026.106916_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004424","article-title":"Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I\/II trial","volume":"10","author":"Aggarwal","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.pep.2026.106916_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.1775","article-title":"Targeting immunotherapy for bladder cancer using anti-CD3\u00d7 B7-H3 bispecific antibody","volume":"7","author":"Ma","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.pep.2026.106916_bib29","first-page":"1","article-title":"T cell cytotoxicity toward hematologic malignancy via B7-H3 targeting","volume":"38","author":"Sun","year":"2019","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.pep.2026.106916_bib30","first-page":"13","article-title":"Preclinical evaluation of DB-1419, a novel bifunctional and bispecific Anti\u2013B7-H3 \u00d7 PD-L1 antibody\u2013drug conjugate open access","volume":"31","author":"Li","year":"2010","journal-title":"Clin. Cancer Res."}],"container-title":["Protein Expression and Purification"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592826000392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592826000392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:00:18Z","timestamp":1778569218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046592826000392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"alternative-id":["S1046592826000392"],"URL":"https:\/\/doi.org\/10.1016\/j.pep.2026.106916","relation":{},"ISSN":["1046-5928"],"issn-type":[{"value":"1046-5928","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Construction of a novel B7H3 VHH-Fc antibody with potent antitumor activity and NK\/T cell activation","name":"articletitle","label":"Article Title"},{"value":"Protein Expression and Purification","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pep.2026.106916","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106916"}}